Skip to content
value.today

Hypera S.A. vs Supernus Pharmaceuticals, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Supernus Pharmaceuticals, Inc. is the larger company by market value: $2.8 B against $2.5 B for Hypera S.A., 1.1 times as much (market caps of Nov 18, 2026 for Hypera S.A. and Aug 1, 2026 for Supernus Pharmaceuticals, Inc.). Hypera S.A.'s value is an estimate (B3 São Paulo close of 18 Nov 2026 x the share count implied by the market cap reported for 01 Aug 2026). Supernus Pharmaceuticals, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • Hypera S.A. had more revenue: $1.6 B in the year to December 2022 against $719 M for Supernus Pharmaceuticals, Inc. in the year to December 2025.
  • Hypera S.A. made a net profit of $359 M, while Supernus Pharmaceuticals, Inc. made a net loss of $39 M.
  • Hypera S.A. keeps more of each dollar of sales: a net margin of 22.5% against -5.4% for Supernus Pharmaceuticals, Inc.
  • Hypera S.A. employs more people: 9,000 against 575 at Supernus Pharmaceuticals, Inc. Each employee brings in about $177,222 of revenue at Hypera S.A. and $1,250,348 at Supernus Pharmaceuticals, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0631261892522020202120222023202420252026Hypera S.A. 43Supernus Pharmaceuticals, Inc. 229

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$1B$1B201720182019202020212022202320242025Supernus Pharmaceuticals, Inc. $1B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureHypera S.A.
HYPE3.SA · #5,585 in the world
Supernus Pharmaceuticals, Inc.
SUPN · #5,225 in the world
Profile
Country🇧🇷 Brazil🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded2001—
Size
Market cap$2.5 B$2.8 B
Revenue$1.6 B$719 M
Net income$359 M▲ best$-39 M
Employees9,000575
Valuation
P/E ratio7.0×—
Price to sales1.6×3.2×
Price to book1.1×2.6×
Free cash flow yield—1.6%
Profitability
Gross margin—89.6%
Operating margin—-8.7%
Net margin—-5.4%
Return on equity—-3.7%
Growth
Revenue growth—8.6%
Revenue growth, 3 years a year—2.5%
Cash
Free cash flow margin—6.4%
Altman Z-score zone—safe
Data as ofMarket cap Nov 2026Market cap Aug 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Hypera S.A. or Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. is the larger company by market value: $2.8 B against $2.5 B for Hypera S.A., 1.1 times as much (market caps of Nov 18, 2026 for Hypera S.A. and Aug 1, 2026 for Supernus Pharmaceuticals, Inc.). Hypera S.A.'s value is an estimate (B3 São Paulo close of 18 Nov 2026 x the share count implied by the market cap reported for 01 Aug 2026). Supernus Pharmaceuticals, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Hypera S.A. or Supernus Pharmaceuticals, Inc.?

Hypera S.A. had more revenue: $1.6 B in the year to December 2022 against $719 M for Supernus Pharmaceuticals, Inc. in the year to December 2025. Hypera S.A. made a net profit of $359 M, while Supernus Pharmaceuticals, Inc. made a net loss of $39 M.

Which is more profitable, Hypera S.A. or Supernus Pharmaceuticals, Inc.?

Hypera S.A. keeps more of each dollar of sales: a net margin of 22.5% against -5.4% for Supernus Pharmaceuticals, Inc.

Which has more employees, Hypera S.A. or Supernus Pharmaceuticals, Inc.?

Hypera S.A. employs more people: 9,000 against 575 at Supernus Pharmaceuticals, Inc. Each employee brings in about $177,222 of revenue at Hypera S.A. and $1,250,348 at Supernus Pharmaceuticals, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.